|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
107.78(B) |
Last
Volume: |
6,390,272 |
Avg
Vol: |
8,439,653 |
52
Week Range: |
$48.64 - $74.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
112,406 |
285,756 |
784,747 |
1,896,260 |
Total Sell Value |
$7,853,005 |
$18,081,559 |
$44,400,077 |
$93,901,157 |
Total People Sold |
7 |
9 |
11 |
13 |
Total Sell Transactions |
11 |
21 |
38 |
73 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nicholas Peter M |
Director |
|
2010-08-06 |
4 |
AS |
$5.74 |
$143,400 |
I/I |
(25,000) |
7,556,021 |
|
- |
|
Abele John E |
Director |
|
2010-08-05 |
4 |
AS |
$5.78 |
$289,185 |
I/I |
(50,000) |
354,200 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-08-05 |
4 |
AS |
$5.79 |
$144,690 |
I/I |
(25,000) |
7,581,021 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-08-04 |
4 |
AS |
$5.66 |
$141,380 |
I/I |
(25,000) |
7,606,021 |
|
- |
|
Abele John E |
Director |
|
2010-08-04 |
4 |
AS |
$5.68 |
$284,160 |
I/I |
(50,000) |
404,200 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-08-03 |
4 |
AS |
$5.56 |
$139,033 |
I/I |
(25,000) |
7,631,021 |
|
- |
|
Abele John E |
Director |
|
2010-08-03 |
4 |
AS |
$5.56 |
$277,775 |
I/I |
(50,000) |
454,200 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-08-02 |
4 |
D |
$5.54 |
$6,338 |
D/D |
(1,144) |
28,976 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,118 |
30,120 |
|
- |
|
Abele John E |
Director |
|
2010-08-02 |
4 |
AS |
$5.59 |
$279,620 |
I/I |
(50,000) |
504,200 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-08-02 |
4 |
AS |
$5.59 |
$139,648 |
I/I |
(25,000) |
7,656,021 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-07-30 |
4 |
AS |
$5.59 |
$139,798 |
I/I |
(25,000) |
7,681,021 |
|
- |
|
Abele John E |
Director |
|
2010-07-30 |
4 |
AS |
$5.59 |
$279,655 |
I/I |
(50,000) |
554,200 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-07-29 |
4 |
D |
$5.60 |
$12,214 |
D/D |
(2,181) |
40,432 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, Endovascular |
|
2010-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
42,613 |
|
- |
|
Abele John E |
Director |
|
2010-07-29 |
4 |
AS |
$5.63 |
$281,430 |
I/I |
(50,000) |
604,200 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-07-29 |
4 |
D |
$5.60 |
$8,562 |
D/D |
(1,529) |
27,002 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2010-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
28,531 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-07-29 |
4 |
AS |
$5.62 |
$140,583 |
I/I |
(25,000) |
7,706,021 |
|
- |
|
Abele John E |
Director |
|
2010-07-28 |
4 |
AS |
$5.79 |
$289,605 |
I/I |
(50,000) |
654,200 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-07-28 |
4 |
AS |
$5.80 |
$144,945 |
I/I |
(25,000) |
7,731,021 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-07-27 |
4 |
AS |
$5.93 |
$148,330 |
I/I |
(25,000) |
7,756,021 |
|
- |
|
Abele John E |
Director |
|
2010-07-27 |
4 |
AS |
$5.93 |
$296,400 |
I/I |
(50,000) |
704,200 |
|
- |
|
Nicholas Peter M |
Director |
|
2010-07-26 |
4 |
AS |
$5.95 |
$148,703 |
I/I |
(25,000) |
7,781,021 |
|
- |
|
Abele John E |
Director |
|
2010-07-26 |
4 |
AS |
$5.94 |
$445,743 |
I/I |
(75,000) |
754,200 |
|
- |
|
1823 Records found
|
|
Page 35 of 73 |
|
|